Complete Genomics is a pioneering life sciences company, headquartered in San Jose, California. Our mission is to drive genomics forward with complete sequencing solutions that improve lives. Since our establishment in 2005, we have consistently led the way in the development of high-throughput sequencing technology. Our extensive product lineup encompasses sample extraction, library preparation, lab automation, DNBSEQ sequencing, and data analysis. To learn more, visit www.completegenomics.com
Clinical Genomics is dedicated to improving patient outcomes through early detection of colorectal cancer. Clinical Genomics products span the full spectrum of colorectal cancer testing, including InSure® ONE™, a fecal immunochemical test for screening in healthy adults, to COLVERA®, a proprietary blood test identifying circulating tumor DNA in patients post-treatment for early detection of recurrence and residual disease. Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer care management. Clinical Genomics continues to apply its proprietary innovation in molecular pathology to commercialize other diagnostic tools in other cancer types.
Clinical Genomics has offices and CLIA-certified laboratories in Bridgewater as well as FDA-registered and TGA-licensed IVD manufacturing in Edison, New Jersey and Sydney, Australia and a NATA-accredited laboratory in North Ryde, NSW Australia.